DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Global Drug Delivery Partnering 2010-2016: Deal trends, players and financials" report to their offering.
The Global Drug Delivery Partnering 2010-2016 report provides comprehensive understanding and unprecedented access to the drug delivery partnering deals and agreements entered into by the worlds leading healthcare companies.
This report provides details of the latest Drug Delivery agreements announced in the life sciences since 2010.
The report takes the reader through a comprehensive review Drug Delivery deal trends, key players, top deal values, as well as deal financials, allowing the understanding of how, why and under what terms, companies are entering Drug Delivery partnering deals.
The report presents financial deal term values for Drug Delivery deals, listing by headline value, upfront payments, milestone payments and royalties, enabling readers to analyse and benchmark the financial value of deals.
Drug Delivery Partnering Terms and Agreements includes:
- Trends in Drug Delivery dealmaking in the biopharma industry since 2010
- Analysis of Drug Delivery deal structure
- Access to headline, upfront, milestone and royalty data
- Case studies of real-life Drug Delivery deals
- Access to Drug Delivery contract documents
- Leading Drug Delivery deals by value since 2010
- Most active Drug Delivery dealmakers since 2010
In Global Drug Delivery Partnering 2010-2016: Deal trends, players, financials and forecasts, the available deals are listed by:
- Company A-Z
- Headline value
- Stage of development at signing
- Deal component type
- Specific therapy target
- Technology type
Key Topics Covered:
2 Trends in Drug Delivery dealmaking
3 Leading Drug Delivery deals
4 Most active Drug Delivery dealmakers
5 Drug Delivery contracts dealmaking directory
6 Drug Delivery dealmaking by technology type
7 Partnering resource center
For more information about this report visit http://www.researchandmarkets.com/research/2ctwdf/global_drug